ⓘ Quick reference

For a full breakdown of each medication — mechanisms, evidence, side effects, what to tell your neurologist before starting, and 17 questions to bring to your appointment — read the FND Medication Guide. This page is the at-a-glance summary.

Pain and Sensory Symptom Medications (incl. AEDs)

Neuropathic-type pain and troublesome sensory symptoms are among the most common reasons a person with FND sees a neurologist. The dominant category here is antiepileptic drugs (AEDs) — gabapentinoids such as gabapentin and pregabalin, plus topiramate — repurposed for neuropathic pain and migraine prophylaxis in FND.

Gabapentin Limited

A gabapentinoid originally developed for epilepsy, now mainly used for neuropathic pain. May help with burning, stabbing, or electric-shock sensations in FND. UK Class C controlled drug; dependence risk with prolonged use.

Topiramate Limited

Antiepileptic with good evidence for migraine prophylaxis. Considered when migraine co-occurs with FND at high rates. Notable side effect: cognitive slowing (sometimes called "Dopamax"). Teratogenic.

Mood, Anxiety, and Pain Sensitisation Medications

Depression, anxiety, and PTSD are common comorbidities in FND. Medications that treat these conditions — particularly SNRIs like duloxetine, which also help with centralised pain — are among the most frequently prescribed.

SSRIs Moderate

Selective serotonin reuptake inhibitors (sertraline, fluoxetine, citalopram). Strong evidence for depression and anxiety in general populations. Limited FND-specific efficacy data, but widely prescribed because of high comorbidity.

SNRIs (duloxetine, venlafaxine) Moderate

Serotonin-noradrenaline reuptake inhibitors. Better evidence than SSRIs for neuropathic pain and central sensitisation. Often preferred when both mood and pain are prominent.

TCAs (amitriptyline, nortriptyline) Limited

Tricyclic antidepressants sometimes used for neuropathic pain, migraine prophylaxis, and co-occurring depression. Notable anticholinergic burden (dry mouth, constipation, urinary retention), pronounced sedation, and cardiac conduction cautions — especially in overdose. Start low, go slow.

Acute anxiety and muscle spasm (short-term only)

NICE recommends limiting benzodiazepine use to 2–4 weeks because of dependence and tolerance. They are not a long-term FND treatment and should be reviewed at every prescription.

Clonazepam Limited

A long-acting benzodiazepine occasionally prescribed for acute anxiety, panic attacks, or significant muscle spasm. NICE guidance cautions against use beyond 2–4 weeks due to dependence risk. Not a long-term FND treatment.

Tremor, POTS, and Adrenergic Symptom Medications

POTS (postural orthostatic tachycardia syndrome) co-occurs with FND at higher rates than in the general population, and functional tremor often has an adrenergic component. Beta-blockers and mineralocorticoids address both.

Propranolol Moderate

Non-selective beta-blocker. Moderate evidence for essential tremor and POTS; widely used for physical anxiety symptoms such as racing heart and shaking. Contraindicated in asthma.

Nadolol Limited

Longer-acting non-selective beta-blocker. Off-label alternative to propranolol when once-daily dosing is preferred. Similar effect on POTS and adrenergic tremor.

Fludrocortisone Moderate

Synthetic mineralocorticoid that increases blood volume. Moderate evidence for managing POTS — reduces lightheadedness and tachycardia on standing, which can in turn reduce FND symptom burden.

When Epilepsy Co-Occurs with FND

Up to 1 in 5 people with epilepsy also have dissociative (non-epileptic) seizures. Antiepileptic drugs are appropriate only when true co-occurring epilepsy has been confirmed by video EEG telemetry.

Levetiracetam Not for PNES alone

A commonly prescribed antiepileptic. Evidence does not support its use for dissociative seizures in the absence of confirmed co-occurring epilepsy. If you have been prescribed it, clarify with your neurologist whether you have confirmed epilepsy that justifies its use.

⚠ What to avoid

Opioids are generally not recommended for FND by leading neurology bodies. Specialist consensus suggests opioids may worsen central sensitisation and perpetuate symptom cycles. If you are currently prescribed an opioid, discuss this with your neurologist — do not stop independently.

Medication Overview at a Glance

A quick comparison of the eight medication classes most commonly discussed in the context of FND. "Limited" does not mean unhelpful — it means FND-specific randomised controlled trial data are lacking.

Medication Symptom Target Evidence Main Risks
Gabapentin Neuropathic pain, sensory symptoms Limited in FND Sedation, dependence, Class C (UK)
SSRIs / SNRIs Depression, anxiety, pain sensitisation Moderate (comorbidities) Initial activation, GI effects, discontinuation
TCAs (amitriptyline, nortriptyline) Depression, neuralgia, migraine prophylaxis Limited in FND Anticholinergic effects, cardiac conduction, sedation, overdose toxicity
Propranolol Tremor, POTS, anxiety Moderate (tremor/POTS) Bradycardia, contraindicated in asthma
Clonazepam Acute anxiety, muscle spasm Limited (short-term) Dependence; avoid long-term use
Topiramate Migraine prophylaxis, pain Limited in FND Cognitive slowing, teratogenic
Fludrocortisone POTS, postural hypotension Moderate (POTS) Fluid retention, electrolyte imbalance
Nadolol POTS, tremor Limited in FND Bradycardia, contraindicated in asthma
Levetiracetam Co-occurring epilepsy only Not recommended for PNES Mood changes, irritability

Patient Checklist Before Starting Medication

Before any new prescription is filled, a short structured conversation with your prescriber protects you from avoidable interactions, helps you set a clear baseline for comparison, and reduces the chance of being left without a review plan. CalmCircuit can directly support step 2 below — a baseline symptom diary entry before the medication starts makes the before-and-after comparison honest.

  1. Full medication + supplement list reviewed. Bring every current prescription, over-the-counter medicine, herbal remedy (St John's Wort, valerian, 5-HTP), and supplement. Interactions are the most common preventable adverse event in neurology prescribing.
  2. Baseline symptom diary entry. Log your symptoms for 1–2 weeks before starting the new drug so any later change can be compared against a known starting point rather than vague recall.
  3. Confirmed diagnosis pathway. Ask what testing has been done and what has been ruled out. For FND specifically, confirm that structural causes (MRI, EEG where appropriate, bloods) have been considered before relying on symptom-targeted prescribing.
  4. Agreed review date + titration plan. When will dose be reviewed? At what dose? What target symptom is being measured? A plan on paper is easier to follow than a verbal "we'll see how it goes."
  5. "Stop / call" criteria written down. Before you start, agree with your prescriber on the specific signs that mean you should stop the drug, call the clinic, or seek urgent care. Get this written into your notes.
  6. Pharmacist counselling on interactions. Your pharmacist will pick up interactions your prescriber may have missed. Take the new prescription in within the first week and ask explicitly about interactions with everything else you take.
  7. Pregnancy / contraception plan where relevant. Topiramate and valproate are teratogenic; gabapentin and pregabalin have limited but real pregnancy data. If pregnancy is possible, agree a contraception plan and pregnancy-testing schedule before the first dose.
⚠ When to call your neurologist

Use these tiers as a quick triage guide. When in doubt, err toward calling — your neurology team would rather hear from you early than miss something time-sensitive.

  • Same day / urgent. New weakness on one side of the body. Sudden vision change. A sudden severe headache unlike your usual pattern. A suspected seizure that caused injury (fall, tongue bite, incontinence). Signs of autonomic crisis — sustained racing heart plus near-fainting, especially when standing.
  • Within 48 hours. New or worsening mood after starting an antidepressant (activation, agitation, or new suicidal thoughts — particularly in the first two weeks). A new rash while taking an AED (Stevens-Johnson syndrome risk). Unexplained bruising or yellowing of the skin or eyes.
  • At your next scheduled review. Side effects tolerable but clearly impairing quality of life. A partial response with residual symptoms you want to discuss. Questions about whether to change the dose, add a second drug, or taper off.
← Continue reading

For the complete breakdown — mechanisms, side effects, what to tell your neurologist before starting, and 17 questions to bring to your next appointment — read FND Medications: What Neurologists Prescribe, What the Evidence Says, and What to Ask.

Track how medications affect your FND symptoms

CalmCircuit lets you log dose changes, side effects, and symptom response day by day — so when an adjustment is on the table, you show your neurologist objective data instead of relying on memory. Particularly valuable during the titration window described in the checklist above.

Start your symptom journal free →

Medical disclaimer

This article is for informational purposes only and does not constitute medical or prescribing advice. Medication decisions must be made with a qualified neurologist or GP who knows your full clinical history. Do not start, stop, or alter doses of any medication without clinical guidance. If you are experiencing a medical emergency, call 999 (UK) or your local emergency services.